May 27, 2026 - May 27, 2026 7:00 - 8:30 PM The IBD Treatment Landscape: TL1A and Small Molecule Advanced Therapies The Gutsy Learning Series (GLS) offers a unique opportunity to learn directly from Canada’s leading experts in inflammatory bowel disease (IBD). Whether you're living with Crohn’s ... Read MoreEn savoir plus LocationEmplacement • Virtual CategoryCatégorie • EducationÉducation
Mar 11, 2019 Takeda Canada announces positive results for ENTYVIO® (vedolizumab) vs. Humira® (adalimumab) in first IBD study to compare biological agents head-to-head Learn moreEn savoir plus
Dec 10, 2018 Connecting patients with specialists in rural and remote communities Learn moreEn savoir plus